Regional differences in coronary revascularization procedures and outcomes: A nationwide 11-year observational study

European Heart Journal - Quality of Care and Clinical Outcomes

Volumn 3, Issue 3, 2017, Pages 243-248

  Vaez, Marjan ^a   Dalén, Magnus ^a,b   Friberg, Örjan ^c   Nilsson, Johan ^d   Frøbert, Ole ^e   Lagerqvist, Bo ^f   Ivert, Torbjörn ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^d LUND UNIVERSITY   (Sweden)

^e Örebro University   (Sweden)

^f UPPSALA UNIVERSITY   (Sweden)

Author keywords

CABG; Outcome; PCI; Regional differences; Sex; Sweden

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; DEATH; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; REVIEW; RISK; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SWEDEN; THERAPY EFFECT; VERY ELDERLY; AGE DISTRIBUTION; CAUSE OF DEATH; CLINICAL TRIAL; FORECASTING; HEART INFARCTION; INCIDENCE; MULTICENTER STUDY; PROCEDURES; SEX RATIO; SURVIVAL RATE; TRENDS;

AGE DISTRIBUTION; AGED; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; INCIDENCE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROSPECTIVE STUDIES; SEX DISTRIBUTION; SURVIVAL RATE; SWEDEN;

EID: 85032030587     PISSN: 20585225     EISSN: 20581742     Source Type: Journal    
DOI: 10.1093/ehjqcco/qcx007     Document Type: Review

References (21)

1. Alter DA, Tu JV, Austin PC, Naylor CD. Waiting times, revascularization modality, and outcomes after acute myocardial infarction at hospitals with and without on-site revascularization facilities in Canada. J Am Coll Cardiol 2003;42:410-419.
2. Hetemaa T, Keskimaki I, Manderbacka K, Leyland AH, Koskinen S. How did the recent increase in the supply of coronary operations in Finland affect socioeconomic and gender equity in their use? J Epidemiol Community Health 2003;57:178-185.
3. Head SJ, Kaul S, Mack MJ Serruys PW, Taggart DP, Holmes DR Jr, Leon MB, Marco J, Bogers AJ, Kappetein AP. The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease. Eur Heart J 2013;34:2510-2518.
4. Hannan EL, Kumar D. Geographic variation in the utilization and choice of procedures for treating coronary artery disease in New York State. Ischaemic Heart Disease Patient Outcomes Research Team (PORT). J Health Serv Res Policy 1997;2:137-143.
5. Black N, Langham S, Petticrew M. Coronary revascularisation: why do rates vary geographically in the UK? J Epidemiol Community Health 1995;49:408-412.
6. Bao Y, Kamble S. Geographical distribution of surgical capabilities and disparities in the use of high-volume providers: the case of coronary artery bypass graft. Med Care 2009;47:794-802.
7. Ben-Shlomo Y, Chaturvedi N. Assessing equity in access to health care provision in the UK: does where you live affect your chances of getting a coronary artery bypass graft? J Epidemiol Community Health 1995;49:200-204.
8. Simes RJ, O'Connell RL, Aylward PE, Varshavsky S, Diaz R, Wilcox RG, Armstrong PW, Granger CB, French JK, Van de Werf F, Marschner IC, Califf R, White HD, Hero-Investigators. Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. Am Heart J 2010;159:988-997.
9. Mohan AV, Fazel R, Huang PH, Shen YC, Howard D. Changes in geographic variation in the use of percutaneous coronary intervention for stable ischemic heart disease after publication of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. Circ Cardiovasc Qual Outcomes 2014;7:125-130.
10. Ko W, Tranbaugh R, Marmur JD, Supino PG, Borer JS. Myocardial Revascularization in New York State: variations in the PCI-to-CABG ratio and their implications. J Am Heart Assoc 2012;1:e001446.
11. McMurtry MS, Southern DA, Lewin AM, Galbraith PD, Kaul P, Ghali WA, Knudtson ML, Graham MM. Recent temporal trends and geographic distribution of cardiac procedures in Alberta. Can J Cardiol 2013;29:460-465.
12. Baig SS, Altman DG, Taggart DP. Major geographical variations in elective coronary revascularization by stents or surgery in England. Eur J Cardiothorac Surg 2015;47:855-859.
13. Authors/Task Force Members, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541-2619.
14. Ljung R, Peterson S, Hallqvist J, Heimerson I, Diderichsen F. Socioeconomic differences in the burden of disease in Sweden. Bull World Health Organ 2005;83:92-99.
15. Humphreys K, Grankvist A, Leu M, Hall P, Liu J, Ripatti S, Rehnstrom K, Groop L, Klareskog L, Ding B, Gronberg H, Xu J, Pedersen NL, Lichtenstein P, Mattingsdal M, Andreassen OA, O'Dushlaine C, Purcell SM, Sklar P, Sullivan PF, Hultman CM, Palmgren J, Magnusson PK. The genetic structure of the Swedish population. PLoS One 2011;6:e22547.
16. Goraya TY, Leibson CL, Palumbo PJ, Weston SA, Killian JM, Pfeifer EA, Jacobsen SJ, Frye RL, Roger VL. Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol 2002;40:946-953.
17. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S, Bertrand M, Fuster V; Freedom Trial Investigators. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012;367:2375-2384.
18. Fortuna D, Nicolini F, Guastaroba P, De Palma R, Di Bartolomeo S, Saia F, Pacini D, Grilli R; Real Investigators. Coronary artery bypass grafting vs percutaneous coronary intervention in a 'real-world' setting: a comparative effectiveness study based on propensity score-matched cohorts. Eur J Cardiothorac Surg 2013;44: e16-e24.
19. Wu C, Zhao S, Wechsler AS, Lahey S, Walford G, Culliford AT, Gold JP, Smith CR, Holmes DR, King SB, Higgins RS, Jordan D, Hannan EL. Long-term mortality of coronary artery bypass grafting and bare-metal stenting. Ann Thorac Surg 2011;92:2132-2138.
20. Molstad P. Survival difference between coronary bypass surgery and percutaneous coronary intervention. Scand Cardiovasc J 2015;49:177-182.
21. Mohr FW, Morice MC, Kappetein AP, Feldman TE, Stahle E, Colombo A, Mack MJ, Holmes DR, Morel MA, Van Dyck N, Houle VM, Dawkins KD, Serruys PW. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013;381:629-638.